Tau hyperphosphorylation at several sites, including those close to its microtubule domain (MD), is considered a key pathogenic event in the development of tauopathies. Nevertheless, we recently demonstrated that at the very early disease stage, tau phosphorylation (pTau) at MD sites promotes neuroprotection by preventing seizure-like activity.
Objective:
To further support the notion that very early pTau is not detrimental, the present work evaluated the young rTg4510 mouse model of tauopathy as a case study. Thus, in mice at one month of age (PN30-35), we studied the increase of pTau within the hippocampal area as well as hippocampal and locomotor function.
Methods:
We used immunohistochemistry, T-maze, nesting test, novel object recognition test, open field arena, and electrophysiology.
Results:
Our results showed that the very young rTg4510 mouse model has no detectable changes in hippocampal dependent tasks, such as spontaneous alternation and nesting, or in locomotor activity. However, at this very early stage the hippocampal neurons from PN30-35 rTg4510 mice accumulate pTau protein and exhibit changes in hippocampal oscillatory activity. Moreover, we found a significant reduction in the somatic area of pTau positive pyramidal and granule neurons in the young rTg4510 mice. Despite this, improved memory and increased number of dendrites per cell in granule neurons was found.
Conclusion:
Altogether, this study provides new insights into the early pathogenesis of tauopathies and provides further evidence that pTau remodels hippocampal function and morphology.
Mondragón-RodríguezS, PerryG, Luna-MuñozJ, Acevedo-AquinoMC, WilliamsS (2014) Phosphorylation of tau protein at sites Ser (396-404) is one of the earliest events in Alzheimer’s disease and Down syndrome. Neuropathol Appl Neurobiol40, 121–135.
3.
Mondragón-RodríguezS, PerryG, Pena-OrtegaF, WilliamsS (2017) Tau, amyloid beta and deep brain stimulation: Aiming to restore cognitive deficit in Alzheimer’s disease. Curr Alzheimer Res14, 40–46.
PievaniM, FilippiniN, Van den HeuvelMP, CappaSF, FrisoniGB (2014) Brain connectivity in neurodegenerative diseases from phenotype to proteinopathy. Nat Rev Neurol10, 620–633.
AhnaouA, MoecharsD, RaeymaekersL, BiermansR, ManyakovNV, BottelbergsA, WintmoldersC, Van KolenK, Van De CasteeleT, KempJA, DrinkenburgWH (2017) Emergence of early alterations in network oscillations and functional connectivity in a tau seeding mouse model of Alzheimer’s disease pathology. Sci Rep7, 14189.
Mondragón-RodríguezS, Salas-GallardoA, González-PereyraP, Martín MacíasM, OrdazB, Peña-OrtegaF, Aguilar-VázquezA, Orta-SalazarE, Díaz-CintraS, PerryG, WilliamsS (2018) Phosphorylation of Tau protein correlates with changes in hippocampal theta oscillations and reduces hippocampal excitability in Alzheimer’s model. J Biol Chem293, 8462–8472.
10.
Mondragón-RodríguezS, Trillaud-DoppiaE, DudilotA, BourgeoisC, LauzonM, LeclercN, BoehmJ (2012) Interaction of endogenous tau with synaptic proteins is regulated by NMDA-receptor dependent tau phosphorylation. J Biol Chem287, 32040–32053.
11.
Mondragón-RodríguezS, PerryG, ZhuX, BoehmJ (2012) Amyloid beta and tau proteins as therapeutic targets for Alzheimer’s disease treatment: Rethinking the current strategy. Int J Alzheimers Dis2012, 630182.
12.
IttnerA, ChuaSW, BertzJ, VolkerlingA, van der HovenJ, GladbachA, PrzybylaM (2016) Site-specific phosphorylation of tau inhibits amyloid-β toxicity in Alzheimer’s mice. Science354, 904–908.
13.
Mondragón-RodríguezS, Salgado-BurgosH, Peña-OrtegaF (2020) Circuitry and synaptic dysfunction in Alzheimer’s disease: A new Tau hypothesis. Neural Plast2020, 2960343.
14.
MulkeyRM, HerronCE, MalenkaRC (1993) An essential role for protein phosphatases in hippocampal long-term depression. Science261, 1051–1055.
CollingridgeGL, PeineauS, HowlandJG, WangYT (2010) Long-term depression in the CNS. Nat Rev Neurosci11, 459–473.
17.
LüscherC, MalenkaRC (2012) NMDA receptor-depen-dent long-term potentiation and long-term depression (LTP/LTD). Cold Spring Harb Perspect Biol4, a005710.
18.
ConnorSA, WangYT (2016) A place at the table: LTD as a mediator of memory genesis. Neuroscientist22, 359–371.
19.
Mondragón-RodríguezS, OrdazB, Orta-SalazarE, Díaz-CintraS, Peña-OrtegaF, PerryG (2020) Hippocampal unicellular recordings and hippocampal-dependent innate behaviors in an adolescent mouse model of Alzheimer’s disease. Bio Protoc10, e3529.
20.
BoekhoornK, TerwelD, BiemansB, BorghgraefP, WiegertO, RamakersGJA, de VosK, KrugersH, TomiyamaT, MoriH, JoelsM, van LeuvenF, LucassenPJ (2016) Improved long-term potentiation and memory in young tau-P301L transgenic mice before onset of hyperphosphorylation and tauopathy. J Neurosci26, 3514–3523.
21.
Alix de CalignonA, Spires-JonesTL, PitstickR, CarlsonGA, HymanBT (2009) Tangle-bearing neurons survive despite disruption of membrane integrity in a mouse model of tauopathy. J Neuropathol Exp Neurol68, 757–761.
22.
Mukaetova-LadinskaEB, HarringtonCR, RothM, WischikCM (1993) Biochemical and anatomical redistribution of tau protein in Alzheimer’s disease. Am J Pathol143, 565–578.
23.
Mondragón-RodríguezS, MenaR, BinderLI, SmithMA, PerryG, García-SierraF (2008) Conformational changes and cleavage of tau in Pick bodies parallel the early processing of tau found in Alzheimer pathology. Neuropathol Appl Neurobiol34, 62–75.
24.
LalondeR (2002) The neurobiological basis of spontaneous alternation. Neurosci Biobehav Rev26, 91–104.
DeaconRMJ, RawlinsJNP (2006) T-maze alternation in the rodent. Nat Prot1, 7–12.
27.
DeaconRMJ (2006) Assessing nest building in mice. Nat Protoc1, 1117–1119.
28.
Salgado-PugaK, Prado-AlcaláRA, Peña-OrtegaF (2015) Amyloid β enhances typical rodent behavior while it impairs contextual memory consolidation. Behav Neurol2015, 526912.
29.
SeibenhenerML, WootenMC (2015) Use of the Open Field Maze to measure locomotor and anxiety-like behavior in mice. J Vis Exp96, doi:10.3791/52434
30.
LueptowLM (2017) Novel object recognition test for the investigation of learning and memory in mice. J Vis Exp, 55718.
31.
Mondragón-RodríguezS, GuN, ManseauF, WilliamsS (2018) Alzheimer’s transgenic model is characterized by very early brain network alterations and β-CTF fragment accumulation: Reversal by β-secretase inhibition. Front Cell Neurosci12, 121.
32.
HatchRJ, WeiY, XiaD, GötzJ (2017) Hyperphosphorylated tau causes reduced hippocampal CA1 excitability by relocating the axon initial segment. Acta Neuropathol133, 717–730.
33.
SongL, LuSX, OuyangX, MelchorJ, LeeJ, TerracinaG, WangX, HydeL, HessJF, ParkerEM, ZhangL (2015) Analysis of tau post-translational modifications in rTg4510 mice, a model of tau pathology. Mol Neurodegener10, 14.
34.
SpiresTL, OrneJD, SantaCruzK, PitstickR, CarlsonGA, AsheKH, HymanBT (2006) Region-specific dissociation of neuronal loss and neurofibrillary pathology in a mouse model of tauopathy. Am J Pathol168, 1598–1607.
35.
PelucchiS, StringhiR, MarcelloE (2020) Dendritic spines in Alzheimer’s disease: How the actin cytoskeleton contributes to synaptic failure. Int J Mol Sci21, 908.
36.
DrummondE, PiresG, MacMurrayC, AskenaziM, NayakS, BourdonM, SafarJ, UeberheideB, WisniewskiT (2020) Phosphorylated tau interactome in the human Alzheimer’s disease brain. Brain143, 2803–2817.
37.
KopeikinaJK, PolydoroM, TaiHC, YaegerE, CarlsonGA, PitstickR, HymanBT, Spires-JonesTL (2013) Synaptic alterations in the rTg4510 mouse model of tauopathy. J Comp Neurol521, 1334–1353.
38.
KopeikinaJK, WegmannS, PitstickR, CarlsonGA, BacskaiBJ, BetenskyRA, HymanBT, Spires-JonesTL (2013) Tau causes synapse loss without disrupting calcium homeostasis in the rTg4510 model of tauopathy. PLoS One8, e80834.
39.
DalbyNO, VolbrachtC, HelboeL, LarsenPH, JensenHS, EgebjergJ, ElvangAB (2014) Altered function of hippocampal CA1 pyramidal neurons in the rTg4510 mouse model of tauopathy. J Alzheimers Dis40, 429–442.
40.
HelboeL, EgebjergJ, BarkholtP, VolbrachtC (2017) Early depletion of CA1 neurons and late neurodegeneration in a mouse tauopathy model. Brain Res1665, 22–35.
GoedertM (2018) Tau filaments in neurodegenerative diseases. FEBS Lett14, 2383–2391.
43.
IttnerLM, KeYD, DelerueF, BiM, GladbachA, van EerselJ, WölfingH, ChiengBC, ChristieMDJ, NapierIA, EckertA, StaufenbielM, HardemanE, GötzJ (2010) Dendritic function of tau mediates amyloid beta toxicity in Alzheimer’s disease mouse models. Cell142, 387–397.
44.
BlackmoreT, MeftahS, MurrayTK, CraigPJ, BlockeelA, PhillipsK, EastwoodB, O’NeillMJ, MarstonH, AhmedZ, GilmourG, GastambideF (2017) Tracking progressive pathological and functional decline in the rTg4510 mouse model of tauopathy. Alzheimers Res Ther9, 77.
45.
ArendashGW, LewisJ, LeightyRE, McGowanE, CracchioloJR, HuttonM, GarciaMF (2004) Multi-metric behavioral comparison of APPsw andP301L models for Alzheimer’s disease: Linkage of poorer cognitive performance to tau pathology in forebrain. Brain Res1012, 29–41.
46.
SantacruzK, LewisJ, SpiresT, PaulsonJ, KotilinekL, IngelssonM, GuimaraesA, DeTureM, RamsdenM, McGowanE, ForsterC, YueM, OrneJ, JanusC, MariashA, KuskowskiM, HymanB, HuttonM, AsheKH (2005) Tau suppression in a neurodegenerative mouse model improves memory function. Science309, 476–481.
47.
MitchisonT, KirschnerM (1988) Cytoskeletal dynamics and nerve growth. Neuron1, 761–772.
48.
AvilaJ, LucasJJ, PerezM, HernandezF (2004) Role of tau protein in both physiological and pathological conditions. Physiol Rev84, 361–384.
49.
GustkeN, TrinczekB, BiernatJ, MandelkowEM, MandelkowE (1994) Domains of tau protein and interactions with microtubules. Biochemistry33, 9511–9522.
50.
EbnethA, GodemannR, StamerK, IllenbergerS, TrinczekB, MandelkowE (1998) Overexpression of tau protein inhibits kinesin-dependent trafficking of vesicles, mitochondria, and endoplasmic reticulum: Implications for Alzheimer’s disease. J Cell Biol143, 777–794.
51.
BaudierJ, LeeSH, ColeRD (1987) Separation of the different microtubule-associated tau protein species from bovine brain and their mode II phosphorylation by Ca2+/phospholipid-dependent protein kinase C. J Biol Chem262, 17584–17590.
52.
HangerDP, HughesK, WoodgettJR, BrionJP, AndertonBH (1992) Glycogen synthase kinase-3 induces Alzheimer’s disease-like phosphorylation of tau: Generation of paired helical filament epitopes and neuronal localisation of the kinase. Neurosci Lett147, 58–62.
53.
ChoJH, JohnsonGVW (2002) Glycogen synthase kinase 3beta (GSK3 beta) phosphorylates tau at both primed and unprimed sites: Differential impact on microtubule binding. J Biol Chem278, 187–193.
54.
ShiptonOA, LeitzJR, DworzakJ, ActonCEJ, TunbridgeEM, DenkF, DawsonHN, VitekMP, Wade-MartinsR, PaulsenO, Vargas-CaballeroM (2011) Tau protein is required for amyloid beta-induced impairment of hippocampal long-term potentiation. J Neurosci31, 1688–1692.
55.
ReganP, PiersT, YiJH, KimDH, HuhS, ParkSJ, RyuJH, WhitcombDJ, ChoK (2015) Tau phosphorylation at serine 396 residue is required for hippocampal LTD. J Neurosci35, 4804–4812.
56.
DottiCG, BankerGA, BinderLI (1987) The expression and distribution of the microtubule-associated proteins tau and microtubule-associated protein 2 in hippocampal neurons in the rat in situ and in cell culture. Neuroscience23, 121–130.
57.
KopkeE, TungYC, ShaikhS, AlonsoAC, IqbalK, Grundke-IqbalI (1993) Microtubule-associated protein tau. Abnormal phosphorylation of a non-paired helical filament pool in Alzheimer disease. J Biol Chem268, 24374–24384.
58.
Mondragón-RodríguezS, Basurto-IslasG, Santa-MariaI, MenaR, BinderLI, AvilaJ, SmithMA, PerryG, García-SierraF (2008) Cleavage and conformational changes of tau protein follow phosphorylation during Alzheimer’s disease. Int J Exp Pathol89, 81–90.
59.
RamsdenM, KotilinekL, ForsterC, PaulsonJ, McGowanE, SantaCruzK, GuimaraesA, YueM, LewisJ, CarlsonG, HuttonM, AsheKH (2005) Age dependent neurofibrillary tangle formation, neuron loss, and memory impairment in a mouse model of human tauopathy (P301L). J Neurosci25, 10637–10647.
60.
BallatoreC, LeeVMY, TrojanowskiJQ (2007) Tau-mediated neurodegeneration in Alzheimer’s disease and related disorders. Nat Rev Neurosci8, 663–672.
LiuY, LvK, LiZ, YuACH, ChenJ, TengJ (2012) PACSIN1, a Tau-interacting protein, regulates axonal elongation and branching by facilitating microtubule instability. J Biol Chem287, 39911–39924.
63.
Mondragón-RodríguezS, GuN, FasanoC, Peña-OrtegaF, WilliamsS (2019) Functional connectivity between hippocampus and lateral septum is affected in very young Alzheimer’s transgenic mouse model. Neuroscience401, 96–105.
64.
Dávila-BouziguetE, Targa-FabraG, ÁvilaJ, SorianoE, PascualM (2019) Differential accumulation of Tau phosphorylated at residues Thr231, Ser262 and Thr205 in hippocampal interneurons and its modulation by Tau mutations (VLW) and amyloid-β peptide. Neurobiol Dis125, 232–244.
65.
CowanRL, WilsonCJ (1994) Spontaneous firing patterns and axonal projections of single corticostriatal neurons in the rat medial agranular cortex. J Neurophysiol71, 17–32.
66.
PagliardiniS, FunkGD, DicksonCT (2013) Breathing and brain state: Urethane anesthesia as a model for natural sleep. Respir Physiol Neurobiol188, 324–332.
67.
CriminsJL, RocherAB, LuebkeJI (2012) Electrophysiological changes precede morphological changes to frontal cortical pyramidal neurons in the rTg4510 mouse model of progressive tauopathy. Acta Neuropathol124, 777–795.
68.
BoothCA, WittonJ, NowackiJ, Tsaneva-AtanasovaK, JonesMW, RandallAD, BrownJT (2016) Altered intrinsic pyramidal neuron properties and pathway-specific synaptic dysfunction underlie aberrant hippocampal network function in a mouse model of tauopathy. J Neurosci36, 350–363.
69.
AmilhonB, HuhCYL, ManseauF, DucharmeG, NicholH, AdamantidisA, WilliamsS (2015) Parvalbumin interneurons of hippocampus tune population activity at theta frequency. Neuron86, 1277–1289.
